Skip to main content
:::Menu
What's New Online Registration Patient Guide Features Honors Health Examination Stories International Medical Service Center
:::Department of Nuclear Medicine > Medical Team
:::Department of Nuclear Medicine > Medical Team

Yi-Jing Lin

Cited (4)
Updated 2024/2/19 10:55:01
Hits 2167
The SUV analysis of SPECT/CT for MullerWeiss disease

CURRICULUM VITAE

03

Basic Information

Name: Yi-Ching Lin

Sex: Female

Current position:

  • Attending physician of Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan (Nov. 2014 ~)
  • Vice director of radiotherapy ward (W131), Taichung Veterans General Hospital, Taichung, Taiwan (Aug. 2016~)
  • Education and therapy committee member of Society of Nuclear Medicine, Taiwan (R.O.C) (Feb. 2019~)
  • Lecturer of Central Taiwan University of Science and Technology, Taichung, Taiwan(Jan. 2020~)

E-mail: ylin@vghtc.gov.tw
Field of Interest:
Nuclear medicine and molecular imaging for endocrinology,
Nuclear medicine imaging for benign bone disease.

Experience and Education

Work Experience:
Internship and PGY year:
China Medical University Hospital, Taichung, Taiwan (2007-2009)
Residency:
Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan (Aug. 2009 – Jan. 2013)
Chief Residency:
Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan (Jan. 2013- Oct. 2014)
Attending physician:
Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan (Nov. 2014 ~)

Education:
-- M.D., China Medical University, Taichung, Taiwan (2000-2007)
-- Ph.D. program in Department of Public Health, China Medical University, Taiwan (2016 ~ )

Publication
  1. Yin Lin, Yu Y. Lu, Hsin Y. Wang, Shih C. Tsai, and Wan Y. Lin*Accidental Finding of Bladder Cancer in 99mTc Methylene Diphosphonate Whole-Body Bone Scan. Clinical nuclear medicine 2013.Volume 38, Number 8, P. 643-645
  2. YIN LIN, WAN-YU LIN, CHIA-HUNG KAO, KUO-YANG YEN, SHANG-WEN CHEN and JUN-JUN YEH. Prognostic Value of Preoperative Metabolic Tumor Volume on PET-CT in Predicting Disease-free Survival of Patients with Stage I Non-small Cell Lung Cancer. ANTICANCER RESEARCH 32: 5087-5092 (2012)
  3. Yin Lin, Wan Y. Lin, Ji A. Liang, Yu Y. Lu, Hsin Y. Wang, Shih C. Tsai, Chia H. Kao. Opportunities for 2-[18F] Fluoro-2-Deoxy-D-Glucose PET/CT in Cervical-Vaginal Neuroendocrine Carcinoma: Case Series and Literature Review. Korean J Radiol 2012;13(6):760-770
  4. Lin Y, Lin WY, Kao CH, *Tsai SC. Easy Interpretation of Heterotopic Ossification Demonstrated on Bone SPECT/CT. Clin Nucl Med. 2014 Jan;39(1):62-3
  5. Lin Y, Jeng LB, Wang HY, Tsai SC, Lin WY, Kao CH. Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma. Technol Cancer Res Treat. 2015 Oct;14(5): 593-599
  6. Lin YC, Lin WY, Tsai SC. Detecting secondary hyperparathyroidism Using Tc-99m Sestamibi SPECT/CT fusion Imaging in Parient with End-Stage Renal Disease. Ann of Nucl Med. 2018;31:109-118.
  7. Chia Ni Lee, Yi-Ching Lin, He-Yuan Hsieh, Jui-Yin Kung, Chun Ting Chiang, Jyh-Cheng Chen, Shih-Chuan Tsa. Prognosis Prediction NPC Based on Radiomics Models Of F-18 FDG PET/CT Images. J Case Rep Clin Images. 2023: 6(1): 1136.
 
     Publication in International Meeting
 
  1. Poster Publisher in 2015 EANM — 28th ANNUAL CONGRESS of the EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE :Preoperative Staging of Urinary Bladder Carcinoma by F-18 FDG PET/CT Using a Novel Protocol- A Prospective Study
  2. Poster Publisher in 2016 JSNM – The 56th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Poster :Clinical Usefulness of Bone SPECT/CT Hybrid Images in Detection of Fractures.
  3.  Poster Publisher Asia Oceania Congress of Nuclear Medicine and Biology ( AOCNMB 2017) in Yokohama, Japan : Correlations between SUVmax of 18F FDG-PET/CT and Clinical Characteristics inHealthy Subjects
  4. Oral repost:The SUV analysis of SPECT/CT for MullerWeiss disease
     
Go Top